Cogent Biosciences Inc (NASDAQ: COGT) on Tuesday, plunged -0.28% from the previous trading day, before settling in for the closing price of $7.26. Within the past 52 weeks, COGT’s price has moved between $3.72 and $12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.02%. The company achieved an average annual earnings per share of 10.00%. With a float of $94.03 million, this company’s outstanding shares have now reached $113.86 million.
Let’s determine the extent of company efficiency that accounts for 205 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cogent Biosciences Inc is 17.41%, while institutional ownership is 100.06%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 10.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.94% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Cogent Biosciences Inc (COGT) is currently performing well based on its current performance indicators. A quick ratio of 5.13 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.38, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.89 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 2.76 million, which is a jump from its year-to-date volume of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 43.44%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 54.74%, which indicates a significant decrease from 75.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.94% in the past 14 days, which was lower than the 82.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.52, while its 200-day Moving Average is $8.09. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $7.45. Second resistance stands at $7.66. The third major resistance level sits at $7.91. If the price goes on to break the first support level at $6.98, it is likely to go to the next support level at $6.73. Now, if the price goes above the second support level, the third support stands at $6.52.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
Market capitalization of the company is 824.32 million based on 113,856K outstanding shares. Right now, sales total 0 K and income totals -255,860 K. The company made 0 K in profit during its latest quarter, and -71,990 K in sales during its previous quarter.
